1. Home
  2. DSS vs INTS Comparison

DSS vs INTS Comparison

Compare DSS & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSS
  • INTS
  • Stock Information
  • Founded
  • DSS 1984
  • INTS 2012
  • Country
  • DSS United States
  • INTS United States
  • Employees
  • DSS N/A
  • INTS N/A
  • Industry
  • DSS Containers/Packaging
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSS Consumer Discretionary
  • INTS Health Care
  • Exchange
  • DSS Nasdaq
  • INTS Nasdaq
  • Market Cap
  • DSS 11.6M
  • INTS 10.9M
  • IPO Year
  • DSS N/A
  • INTS 2023
  • Fundamental
  • Price
  • DSS $1.28
  • INTS $0.23
  • Analyst Decision
  • DSS
  • INTS Strong Buy
  • Analyst Count
  • DSS 0
  • INTS 4
  • Target Price
  • DSS N/A
  • INTS $4.50
  • AVG Volume (30 Days)
  • DSS 788.2K
  • INTS 4.0M
  • Earning Date
  • DSS 11-12-2025
  • INTS 11-12-2025
  • Dividend Yield
  • DSS N/A
  • INTS N/A
  • EPS Growth
  • DSS N/A
  • INTS N/A
  • EPS
  • DSS N/A
  • INTS N/A
  • Revenue
  • DSS $21,252,000.00
  • INTS N/A
  • Revenue This Year
  • DSS N/A
  • INTS N/A
  • Revenue Next Year
  • DSS N/A
  • INTS N/A
  • P/E Ratio
  • DSS N/A
  • INTS N/A
  • Revenue Growth
  • DSS 10.24
  • INTS N/A
  • 52 Week Low
  • DSS $0.72
  • INTS $0.19
  • 52 Week High
  • DSS $1.90
  • INTS $4.30
  • Technical
  • Relative Strength Index (RSI)
  • DSS 56.02
  • INTS 32.86
  • Support Level
  • DSS $1.10
  • INTS $0.27
  • Resistance Level
  • DSS $1.44
  • INTS $0.30
  • Average True Range (ATR)
  • DSS 0.24
  • INTS 0.02
  • MACD
  • DSS -0.00
  • INTS -0.00
  • Stochastic Oscillator
  • DSS 41.80
  • INTS 6.39

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: